Model
Edge
Lyell Immunopharma Inc.
0001866154
Filing Type
4
Filing Date
2/12/2024
Updated
2/13/24, 1:24 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership